PHARMACIE NEUVE
ActiveSummary
PHARMACIE NEUVE has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €211,892 and a net result of €7,599. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 54% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 27-06-2001 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.098.531.256 4032 Liège, since 06-11-2001
- Financial year end
- 31 December
- Peppol
- Reachable since 09-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €194,511
- ▼ 16.8%
- Turnover
- ≈ €910,000
- estimated
- Profit
- €7,599
- ▼ 83.3%
- Equity
- €211,892
- ▲ 3.3%
- Total assets
- €530,084
- ▼ 13.4%
- Employees on 31-12-2025
- 3
- =
- 2025 accounts filed 20 days after the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 2001Liquidity: current ratio 1.59, cash €83,833Equity €211,892 (40.0% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 55% of them on solvency, 56% on liquidity, 52% on profitability and 48% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 1 day after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
- Positive: 6 profitable years in a rowprofit 2025: €7,599 6 years View
Recent changes
- · Gazette deed Amendment of the articles · Legal-form change · Resignations & appointmentsResignation: LEWALLE Véronique (manager) · Reappointment: LEWALLE Véronique (director)
Comparable companies
These companies have the same main activity as PHARMACIE NEUVE: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €452,000 and €605,000, founded between 1999 and 2005.
| Company | Total assets | Gross margin |
|---|---|---|
| PHARMACIE NEUVE Liège | €530,084 | €194,511 |
| PHARMACIE THIBAUT -BOUCART Frasnes-lez-Anvaing | €508,834 | €178,681 |
| PHARMACIE MOSSERAY Anhée | €557,870 | €197,665 |
| PHARMACIE DEMEULDRE - DEGIVE Esneux | €604,841 | €172,114 |
| PHARMACIE DE ROBERMONT Liège | €527,522 | €206,901 |
| PHARMACIE DELVIGNE DOUMONT Genappe | €451,687 | €189,736 |
| DIEPENBEEK MARKT FARMA Diepenbeek | €505,908 | €224,604 |
Key facts about PHARMACIE NEUVE
- What is the company number of PHARMACIE NEUVE?
- The company number of PHARMACIE NEUVE is 0475.096.003. The VAT number is the same number with BE in front: BE 0475.096.003.
- Where is PHARMACIE NEUVE based?
- The registered office is at Rue Neuve 9, 4032 Liège.Company details
- What does PHARMACIE NEUVE do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMACIE NEUVE?
- The legal form of PHARMACIE NEUVE is Private limited company (BV).
- When was PHARMACIE NEUVE founded?
- PHARMACIE NEUVE was founded on 27-06-2001.
- Is PHARMACIE NEUVE still active?
- Yes, PHARMACIE NEUVE is an active enterprise in the KBO register.
- How many employees does PHARMACIE NEUVE have?
- PHARMACIE NEUVE had an average of 1.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does PHARMACIE NEUVE fall under?
- In its 2025 annual accounts, PHARMACIE NEUVE states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of PHARMACIE NEUVE?
- The turnover in financial year 2025 is ≈ €910,000. This figure is estimated from the gross margin of €194,511 and 51 comparable companies (NACE 477). It probably lies between €620,000 and €1.8m.
- Is PHARMACIE NEUVE profitable?
- In financial year 2025, PHARMACIE NEUVE made a profit of €7,599.
- Where can I find the annual accounts of PHARMACIE NEUVE?
- PHARMACIE NEUVE filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMACIE NEUVE due?
- PHARMACIE NEUVE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.